NCT06867302View on ClinicalTrials.gov

Dexmedetomidine and Agitation After Nasal Surgery

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

September 1, 2025

Study Completion Date

October 1, 2025

Conditions
Nasal DiseaseAgitation, Emergence
Interventions
DRUG

Dexmedetomidine in 0.9 % NaCl 1,000 Mcg/250 mL (4 Mcg/mL) INTRAVEN INFUSION BOTTLE (ML)

An infusion given all through intraoperative time

DRUG

Dexmedetomidine Injection [Precedex]

Single dose given 15 minutes before end of surgery

Trial Locations (1)

63514

RECRUITING

Fayoum University Hospital, Al Fayyum

All Listed Sponsors
lead

Fayoum University Hospital

OTHER